… of first allografts, of first autografts, of first CAR-T, of first gene therapy  (rows 1-38 and sum in row 39) and … of additional transplants or retransplants or additional CAR-T/gene therapy  performed due to disease progression, …

… on the outcome of recipients of an allogeneic HSCT or CAR T-cell therapy’ will be given by Dr Rodrigo Martino of the … resulting in an unquantifiable number of alloHCT and CAR-T cell candidates who will never receive their otherwise …

… of cellular therapies, including allogeneic HCT and novel CAR-T cells, should be re-evaluated. A group of international …

… began during medical school in Vienna, where I worked on T cell vaccines against systemic and mucosal pathogens. After … and therefore may be important for other T cell-mediated therapies that are influenced by the gut microbiome such as CAR-T cells or immune checkpoint inhibitors. Our data …

… projects including in-house point of care manufacturing of CAR-T cells, in addition to facilitating the treatment of our patients with commercially available CAR T-cells. The laboratory supports several clinical trials …

… our work field. Dr. Julio Delgado presented the Barcelona CAR-T story as an example of a successful public or academic …

… and without the EBMT Nurses Group's support, I wouldn’t have been able to attend the Annual Meeting. I think I … recognition.  I am currently advancing my training in CAR-T therapy, and it was highly educational listen to … on this subject and patient management undergoing CAR-T therapy in other countries. From my perspective, …

… allogeneic and autologous stem cells transplantations and CAR-T cells therapies. Laura attended the JACIE Inspector …

… study is: ‘ Uncovering the mode of action of engineered T cells in patient cancer organoids ’ The link to the full … we applied to understand and improve the mode of action of T cell immunotherapy against cancer. This research led to the … you decide to do this study? A: T-cell therapies, such as CAR-T cells, are a promising type of immunotherapy that are …

… immunotherapies with a focus on patients treated with CAR-T cells which included references to the EBMT registry. …